Who We Are
The team behind a world of change.

Dr. Ross Cagan

Scientific Advisory Board

Regius Chair of Precision Medicine, University of Glasgow. Formerly, Icahn School of Medicine and Director of Center of Personalised Cancer Therapeutics, Mount Sinai, where he developed PDP methodology.

Michael Elashoff

Scientific Advisory Board

Head of Data Science at Project Ronin. Developed the algorithms behind two validated genomic diagnostic tests (Celmatix, CardioDX).

Dr. Michael Castro

Medical Advisory Board

Neuro & Medical Oncologist, Beverly Hills Cancer. Recognised as one of TopDoctors in America by IS News & World Report.

Dr. Mehra Golshan

Medical Advisory Board

Deputy Chief Medical Officer, Director Breast Program, Chief of Breast Surgery, Yale Cancer Center, Smilow Cancer Hospital. Professor of Surgery, Yale School of Medicine.

Prof. Gary Middleton

Medical Advisory Board

Professor of Medical Oncology, Institute of Immunology and Immunotherapy, University pf Birmingham. Gary sits on the Lung CSG, the NCRI advanced colorectal sub-group, the NCRI pancreatic sub-group and CTAAC.

Dr. Elizabeth Smyth

Medical Advisory Board

Clinical Consultant, gastrointestinal oncology, Addenbrooke’s Hospital, Cambridge.

Dr. Jonas Feilchenfeldt

Medical Advisory Board

Consultant in Medical Oncology, core faculty member ESO, Service d’Oncologie Medical, Rivera-Chablis Hospital, Switzerland.

Matthew Scherba

Corporate Advisory Board

Investor and entrepreneur in creating and scaling early stage technology companies across IoT, software, hardware and AI.

Dr Daniel Krell

Consultant Medical Oncologist

Consultant Medical Oncologist, Royal Free Private, HVA/LOC Harley St, London. Focus on GI cancers and expertise in molecular drivers of cancer.

Dr Niti Pall

Commercial Advisory Board

Medical Director to KPMG’s Global Health Practice. Senior Advisor to AXA. Formerly Medical and Innovation Director of Emerging Markets for BUPA.